| Carlos Alberto Hartmann, MD | |
|
1000 Ochsner Blvd, Covington, LA 70433-8107 | |
| (985) 875-2828 | |
| (985) 898-7492 |
| Full Name | Carlos Alberto Hartmann |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 18 Years |
| Location | 1000 Ochsner Blvd, Covington, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962769141 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Tammany Parish Hospital | Covington, LA | Hospital |
| Ochsner Clinic Foundation | New orleans, LA | Hospital |
| Ochsner Medical Center - Baton Rouge | Baton rouge, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ochsner Clinic Llc | 8224933619 | 2403 |
News Archive
ViroPharma Incorporated and Halozyme Therapeutics announced today that ViroPharma has initiated an open-label, multi-dose Phase 2 study to evaluate the safety, and pharmacokinetics and pharmacodynamics of subcutaneous administration of Cinryze in combination with Halozyme's Enhanze technology, a proprietary drug delivery platform using Halozyme's recombinant human hyaluronidase enzyme, in subjects with hereditary angioedema.
The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial reported at EuroPCR 2013 today.
Nearly 15 million times a year, Americans with heart trouble climb onto a treadmill to take a stress test that can reveal blockages in their heart's blood vessels. It's a major factor in deciding what doctors should do next for them.
Scientists may have discovered a new way to prevent strokes in high risk patients, according to research from the University of Warwick and University Hospitals Coventry and Warwickshire (UHCW).
Harvard Medical School's (HMS) establishment of its $30 million Center for Primary Care is a powerful statement of the importance of primary care and the role major medical institutions must play in its transformation, according to Boston-based nonprofit Primary Care Progress (PCP). PCP credits a dedicated and engaged primary care community, partnering with a visionary dean, for the formation of Harvard's new Center.
› Verified 7 days ago
| Entity Name | Ochsner Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
ViroPharma Incorporated and Halozyme Therapeutics announced today that ViroPharma has initiated an open-label, multi-dose Phase 2 study to evaluate the safety, and pharmacokinetics and pharmacodynamics of subcutaneous administration of Cinryze in combination with Halozyme's Enhanze technology, a proprietary drug delivery platform using Halozyme's recombinant human hyaluronidase enzyme, in subjects with hereditary angioedema.
The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial reported at EuroPCR 2013 today.
Nearly 15 million times a year, Americans with heart trouble climb onto a treadmill to take a stress test that can reveal blockages in their heart's blood vessels. It's a major factor in deciding what doctors should do next for them.
Scientists may have discovered a new way to prevent strokes in high risk patients, according to research from the University of Warwick and University Hospitals Coventry and Warwickshire (UHCW).
Harvard Medical School's (HMS) establishment of its $30 million Center for Primary Care is a powerful statement of the importance of primary care and the role major medical institutions must play in its transformation, according to Boston-based nonprofit Primary Care Progress (PCP). PCP credits a dedicated and engaged primary care community, partnering with a visionary dean, for the formation of Harvard's new Center.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carlos Alberto Hartmann, MD 1514 Jefferson Hwy, New Orleans, LA 70121-2429 Ph: (504) 842-4000 | Carlos Alberto Hartmann, MD 1000 Ochsner Blvd, Covington, LA 70433-8107 Ph: (985) 875-2828 |
News Archive
ViroPharma Incorporated and Halozyme Therapeutics announced today that ViroPharma has initiated an open-label, multi-dose Phase 2 study to evaluate the safety, and pharmacokinetics and pharmacodynamics of subcutaneous administration of Cinryze in combination with Halozyme's Enhanze technology, a proprietary drug delivery platform using Halozyme's recombinant human hyaluronidase enzyme, in subjects with hereditary angioedema.
The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial reported at EuroPCR 2013 today.
Nearly 15 million times a year, Americans with heart trouble climb onto a treadmill to take a stress test that can reveal blockages in their heart's blood vessels. It's a major factor in deciding what doctors should do next for them.
Scientists may have discovered a new way to prevent strokes in high risk patients, according to research from the University of Warwick and University Hospitals Coventry and Warwickshire (UHCW).
Harvard Medical School's (HMS) establishment of its $30 million Center for Primary Care is a powerful statement of the importance of primary care and the role major medical institutions must play in its transformation, according to Boston-based nonprofit Primary Care Progress (PCP). PCP credits a dedicated and engaged primary care community, partnering with a visionary dean, for the formation of Harvard's new Center.
› Verified 7 days ago
Dr. Patricia B Guidry, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 1000 Ochsner Blvd, Covington, LA 70433 Phone: 985-875-2828 | |
Salvatore Buttaci-guarino, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 101 Judge Tanner Blvd Ste 300, Covington, LA 70433 Phone: 985-876-2100 Fax: 985-871-1548 | |
Dr. Farhad X Aduli, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 20 Starbrush Cir, Covington, LA 70433 Phone: 985-777-7000 Fax: 985-777-9000 | |
Joe E Johnson Jr., MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 5001 Highway 190 East Service Rd, Suite A3, Covington, LA 70433 Phone: 985-893-9251 Fax: 985-892-7893 | |
Jessica Gonzalez, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1202 S Tyler St, Covington, LA 70433 Phone: 985-898-4194 Fax: 985-898-4164 | |
Dr. Chris Theodossiou, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 Ochsner Blvd, Covington, LA 70433 Phone: 985-875-2828 | |
Dr. Lauren Hamilton Mcmanus, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 350 Lakeview Ct Ste B, Covington, LA 70433 Phone: 985-730-2230 Fax: 985-730-2231 |